GlobeNewsWire
22 Jun 2026, 06:53 UTC · 2h ago
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
22 Jun 2026, 06:53 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Bavarian Nordic has been awarded a government contract valued at over DKK 700 million for its MVA-BN smallpox/mpox vaccine. — Significant new revenue from a government contract provides a direct boost to the company's financial outlook and validates product demand.
+0.60Bavarian Nordic is executing a share buy-back program of up to DKK 150 million running through July 10, 2026. — Buy-backs typically support the share price by reducing supply and signaling management's confidence in the company's value.
+0.30The company currently holds 3,069,957 treasury shares, representing 3.87% of its total share capital. — Provides a factual update on the progress of the buy-back program but has minimal immediate impact on market sentiment.
+0.10Which stocks this story touches
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Accesswire
2h ago
